Our leadership team

Brent Clough

Chief Executive Officer

Brent Clough co-founded Trio Health in 2013. Prior to this, Brent founded IntrinsiQ Financial in 2004, which merged with IntrinsiQ Research in 2006. IntrinsiQ is the leader for oncology clinical software that tracks and manages complex chemotherapy workflows. With Brent's leadership, IntrinsiQ developed the largest oncology longitudinal patient database, which has been widely adopted by pharmaceutical companies. Upon the merger, Brent was elected President and CEO of the company. The company grew from a start-up to 90 employees prior to being acquired by Amerisource Bergen. Before entering the healthcare industry, Brent spent eight years as a Vice President at Goldman Sachs (1996-2004) working in the investment research and equities division. Prior to Goldman, Brent worked at First Call Corporation (1988-1996) within the institutional sales and broker dealer division.

Yoori Lee

President

Yoori co-founded Trio Health. Yoori spent over 15 years at Leerink Swann LLC, a leading healthcare investment bank where she was Managing Director and Director of MEDACorp Services, and helped to establish the MEDACorp network. Her cadre of experts included more than 35,000 healthcare professionals including, but not exclusive to, clinical medicine, biomedical research, regulatory affairs, public policy, healthcare administration and healthcare information technology. Yoori has delivered value-driving business and decision support strategies to companies ranging from emerging growth to the world's largest pharmaceutical companies. With nearly twenty years of consulting experience, Yoori has unique experience in scientific, clinical, regulatory and commercial solutions for clients by bringing together a best in class network of in-the-trenches consultants into the strategic process. Through these close relationships and collaborations, she has helped to develop intricate consulting strategies, assembled numerous advisory boards, and aligned strategic objectives based upon thorough assessments of competitive landscapes as well as developing and managing pre-and post-marketing programs.

Lenny Goldstein, Ph.D.

Chief Security Officer

For the last 20 years, Lenny was a technologist/CIO for a number of Wall Street firms such as Goldman Sachs, Pequot Capital and Atticus Capital. His expertise includes the role of CIO in the management of technology organizations on an international basis. From 2009 to 2011 Lenny was the COO/Co-Founder of Auxia Partners, providing private cloud computing solutions and virtual CIO offerings to the asset management community. From 2004 to 2009, he was the Chief Information Officer of two different hedge funds: Atticus Capital LP and Pequot Capital Management, a premier hedge fund and venture capital group based in Westport, Connecticut and New York City, NY. Prior to Pequot, he served as the CIO and co-founder of IntraLinks, responsible for all aspects of technology including: Research & Development, ASP Hosting Services, Operations, Information Security, Infrastructure and CRM/ERP systems. As a founding partner, he was instrumental in growing IntraLinks to a major player in the area of digital collaboration. Prior to IntraLinks, he was a Vice President in the Investment Research Department at Goldman, Sachs & Company, responsible for the development, implementation and operation of a large scale international Internet based research delivery system known as the ResearchXpress. Lenny has his Ph.D., MS, and BS in engineering from New York University – Polytechnic School of Engineering.

Kyle Brill

Chief Technology Officer

Kyle brings over a decade of engineering leadership experience spanning ad tech, cloud communications, insurance technology, and consulting. Most recently, he served as Head of AI and Engineering at Crafted, a Denver-based software development consultancy, where he led the company's transformation into an AI-native software development group. In addition to deep cloud and technical expertise, Kyle brings a focus on business outcomes that help teams efficiently serve customers. His teams have built systems for startups and enterprises to discover valuable insights, answer complex questions, and streamline internal operations. Kyle is an active member of the Colorado technical community with participation in CTO Lunches, and he's an advisor to early-stage founders. Kyle holds a degree in Aerospace Engineering from the University of Texas at Austin.

Jen Deuson

Director, Client Engagement

Jen has over 15 years of experience directing the translation of real-world health data into strategic evidence for global biopharmaceutical organizations. Most recently, she spent five years as Director, Customer Success at Aetion, a Datavant Company, where she led RWE/RWD platform strategy and implementation for global biopharma clients, managing a portfolio of programs spanning renal, oncology, immunology, neurology, and rare disease therapeutic areas. Prior to Aetion, Jen served as Project & Strategic Account Manager at HealthiVibe, a Division of Corrona, where she led patient and HCP research programs that directly informed clinical trial design and evidence generation strategy for global pharmaceutical clients. Before HealthiVibe, she spent eight years at DaVita Clinical Research, directing clinical research and real-world evidence projects. Her expertise spans cross-functional team leadership, client engagement, and deploying RWE solutions that accelerate clinical decisions, shape practice, and improve patient outcomes. She holds a Masters in Public Health from the University of California, Los Angeles.

Isobel McEwen

Director, Evidence Strategy & Solutions

Isobel McEwen directs evidence strategy and solutions design at Trio Health, leading the team responsible for study conceptualization, feasibility assessment, and methodological design of custom evidence programs. Her methodological focus is measurement in settings where structured claims and electronic health record data cannot answer the question of interest. Her recent work has included language-model-assisted chart abstraction with clinician adjudication, which ascertained clinical events documented only in provider notes, and utilized multi-source capture and interpretation specifications to address clinical questions that can only be answered by combining provider documentation with patient-reported experience. Designs are specified to pharmacoepidemiologic standards, including active-comparator new-user cohorts, explicit index date and exposure window definitions, and prespecified handling of exposure and outcome misclassification. Her applied experience includes pregnancy safety of pharmaceuticals, HIV treatment and pre-exposure prophylaxis, and clinical trial feasibility and design, spanning sponsor-side and academic clinical settings. Prior to Trio Health, she held positions at Takeda, Boston Children's Hospital, and Alkermes. Isobel holds a Master of Science in Pharmacoepidemiology from the Harvard T.H. Chan School of Public Health and a Bachelor of Science in Pharmaceutical Chemistry from the University of Toronto.